000 | 01399 a2200397 4500 | ||
---|---|---|---|
005 | 20250512195026.0 | ||
264 | 0 | _c19801024 | |
008 | 198010s 0 0 eng d | ||
022 | _a0022-3549 | ||
024 | 7 |
_a10.1002/jps.2600690835 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHuang, C C | |
245 | 0 | 0 |
_aSynthesis and biological evaluation of p-bromospiperone as potential neuroleptic drug. _h[electronic resource] |
260 |
_bJournal of pharmaceutical sciences _cAug 1980 |
||
300 |
_a984-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntipsychotic Agents _xchemical synthesis |
650 | 0 | 4 | _aBinding, Competitive |
650 | 0 | 4 |
_aButyrophenones _xchemical synthesis |
650 | 0 | 4 | _aCattle |
650 | 0 | 4 |
_aCaudate Nucleus _xmetabolism |
650 | 0 | 4 | _aChemical Phenomena |
650 | 0 | 4 | _aChemistry |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aPituitary Gland, Anterior _xmetabolism |
650 | 0 | 4 |
_aProlactin _xblood |
650 | 0 | 4 |
_aReceptors, Dopamine _xdrug effects |
650 | 0 | 4 |
_aSpiperone _xanalogs & derivatives |
700 | 1 | _aFriedman, A M | |
700 | 1 | _aSo, R | |
700 | 1 | _aSimonovic, M | |
700 | 1 | _aMeltzer, H Y | |
773 | 0 |
_tJournal of pharmaceutical sciences _gvol. 69 _gno. 8 _gp. 984-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/jps.2600690835 _zAvailable from publisher's website |
999 |
_c6105292 _d6105292 |